Congratulations to Deciphex for winning the Product Impact Award! #LifeSciencesIRL

🚨 Last 10 tickets! 🚨 Join us at the Diagnexia Histopathology Symposium in Oxford, Aug 21-23. Network with experts, learn from international speakers, and explore the latest in pathology. Secure your spot now before it's too late! news.diagnexia.com/3xWZ35H #DiagnexiaSymposium2024

📢 Exciting News! We've moved to a new US office! New Address: 500 E Diehl Road, Suite 130, Naperville, IL 60563. Effective Date: 23rd July. Our new, larger facility is equipped with advanced state-of-the-art scanners, expanding our capabilities for enhanced service delivery.

Excited to join the 22nd Annual Meeting of the Japanese Society of Digital Pathology and AI in Nago, Okinawa next month! If you're attending, connect with us to learn about our Patholytix ecosystem. Looking forward to sharing our latest developments! #JSDP2024 #DigitalPathology

An amazing day for Deciphex! This level of operational capacity will truly transform the UK for pathology services in the coming years.

Join us for the 4th Diagnexia Symposium at Worcester College, Oxford, Sept 3-5! Last year sold out - secure your spot now! bit.ly/Diagnexia #DiagnexiaSymposium #Pathology

Get ready to explore how AI is shaping pathology! Join us this Thursday, Nov 14 for Part 1 of Diagnexia’s computational pathology series led by CSO Pierre Moulin. Perfect for pathologists & residents! Register now: news.diagnexia.com/3O3tZp9 #ComputationalPathology #MedicalWebinar

We’re at the 'From Pathologist’s Eye to AI' Symposium in Stockholm! Excited to connect with others passionate about advancing #pathology. Let’s talk about how Diagnexia is bringing digital solutions to Sweden. Come say hi! #AI #Diagnostics

Off to busy start to 2025, pleased to announce our UKAS accreditation for our Diagnexia digital pathology reporting service in the UK! More exciting Deciphex news to come next week! #digitalpathology

Deciphex is proud to announce a €31M investment, led by Molten Ventures, to tackle the global pathology shortage & transform diagnostic workflows. Expanding globally & enhancing AI-powered platforms for better care. Learn more:eu1.hubs.ly/H0fG8KF0

Huge day for Deciphex! Many thanks to Molten Ventures and our existing investors for the support and confidence they have shown in the team and our vision to transform pathology! #investment #digitalpathology

Deciphex Secures $32.3M Series C to Address Global Pathology Shortage markets.ft.com/data/announce/… via Financial Times

Delighted to share my perspectives with the Sunday Times on how Deciphex is going to change the game in pathology! #pathology

David Lynch has sadly passed away at the age of 78.

Introducing Diagnexia’s Enterprise Platform for Digital Pathology! Same-day access to board-certified pathologists, drag-and-drop uploads, & HIPAA-compliant security. Faster diagnoses, lower costs, & scalable solutions! Learn more: bit.ly/3Eod7aZ #DigitalPathology

💯🎯

A stunning essay in the FT on the international decline in the ability to read, reason, focus, and learn new things. It began or accelerated in the early 2010s. It's hitting teens AND adults. Self-report and objective scores. by John Burn-Murdoch ft.com/content/a8016c…

Why come to #DiagnexiaSymposium2025? This is the must-attend event for pathologists who want to stay at the forefront of innovation. Over three days, you’ll gain insights from the world’s leading experts through focused lectures and interactive slide seminars on key challenges

Reviewing the composition of the 6th edition WHO Tumour Classification expert panels for breast, female genital, and digestive system tumours, I found that only 5.4% of the experts are from low- and middle-income countries (LMICs). The remaining 94.6% hail from high-income

😂😂😂😂